Glucose B. Braun (Glucose)

Glucose B. Braun is indicated for several clinical situations where intravenous carbohydrate delivery is needed.

• Management of hypoglycemia when oral glucose administration is not feasible.
• Component of parenteral nutrition regimens to provide caloric support.
• Fluid and electrolyte replacement solutions where an energy source is required.
• Adjunct therapy during peri‑operative care to maintain blood glucose stability.
• Support for patients receiving total parenteral nutrition who need a carbohydrate source.

When administered intravenously, glucose solutions can produce a range of physiological responses, most of which are related to blood sugar fluctuations and infusion tolerance.

Common

• Transient hyperglycemia or mild elevation of blood glucose.
• Local irritation or pain at the infusion site.
• Nausea or mild gastrointestinal discomfort.
• Electrolyte shifts, particularly sodium and potassium changes.
• Headache or dizziness related to rapid glucose infusion.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Hypoglycemia after abrupt discontinuation.
• Fluid overload or pulmonary edema in volume‑sensitive patients.
• Allergic or anaphylactic reaction to the solution components.
• Metabolic acidosis in patients with impaired glucose utilization.

Glucose B. Braun should be used with careful clinical assessment, and several precautions are recommended to minimize risks.

• Verify patient’s blood glucose level before and during infusion.
• Adjust infusion rate in patients with renal or cardiac insufficiency.
• Monitor fluid balance to avoid overload, especially in critically ill patients.
• Use compatible infusion sets and avoid mixing with incompatible drugs.
• Consider special dosing in neonates, infants, and patients with impaired glucose metabolism.
• Store the solution according to manufacturer guidelines to maintain sterility.

Glucose solutions can interact with other intravenous agents, affecting their efficacy or safety.

Avoid

• Co‑administration with high‑dose insulin without appropriate monitoring.
• Simultaneous infusion of potassium chloride in concentrations that may precipitate.
• Mixing with calcium‑containing solutions that can cause precipitation.

Use with caution

• Concurrent use of diuretics that may alter electrolyte balance.
• Administration alongside beta‑blockers, which can mask hypoglycemia symptoms.
• Use with other hyperosmolar solutions that increase risk of fluid overload.